Teprotumumab for the treatment of thyroid eye disease: The Holy grail, really?

被引：1
|
作者：
Martel, A. [1 ]
机构：
[1] Cote Azur Univ, Univ Hosp Nice, Ophthalmol Dept, 30, voie Romaine, F-06000 Nice, France
来源：
JOURNAL FRANCAIS D OPHTALMOLOGIE | 2023年 / 46卷 / 06期
关键词：
GRAVES ORBITOPATHY; RITUXIMAB;
D O I：
10.1016/j.jfo.2023.01.003
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：567 / 570
页数：4
相关论文
共 50 条
  • [31] Acquired Epiblepharon Alleviated With Teprotumumab Treatment in Active Thyroid Eye Disease Patient
    Chen, Kevin W.
    Phelps, Paul O.
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2021, 37 (06): : E195 - E196
  • [32] Impact of Teprotumumab on Clinical Practice in Thyroid Eye Disease
    Rachmasari, Kharisa N.
    Toro-Tobon, David
    Wagner, Lilly H.
    Tooley, Andrea A.
    Bradley, Elizabeth A.
    Stan, Marius N.
    ENDOCRINE PRACTICE, 2024, 30 (10) : 937 - 942
  • [33] Teprotumumab for Thyroid Eye Disease-related Strabismus
    Dallalzadeh, Liane O.
    Villatoro, George A.
    Chen, Lillian
    Sim, Myung S.
    Movaghar, Mansoor
    Robbins, Shira L.
    Karlin, Justin N.
    Khitri, Monica R.
    Velez, Federico G.
    Korn, Bobby S.
    Demer, Joseph L.
    Rootman, Daniel B.
    Granet, David B.
    Kikkawa, Don O.
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2024, 40 (04): : 434 - 439
  • [34] Change in upper eyelid position after teprotumumab treatment for thyroid eye disease
    Rosenblatt, Tatiana R.
    Chiou, Carolina A.
    Yoon, Michael K.
    Lee, Nahyoung Grace
    Wolkow, Natalie
    Freitag, Suzanne K.
    ORBIT-THE INTERNATIONAL JOURNAL ON ORBITAL DISORDERS-OCULOPLASTIC AND LACRIMAL SURGERY, 2024, 43 (03): : 337 - 343
  • [35] Audiologic Demonstration of Ototoxicity From Teprotumumab Treatment in a Patient With Thyroid Eye Disease
    Najjar, Wassim
    Yu, Jeffrey
    OTO OPEN, 2022, 6 (02)
  • [36] Reply Re: "Proptosis Regression After Teprotumumab Treatment for Thyroid Eye Disease"
    Rosenblatt, Tatiana R.
    Chiou, Carolina A.
    Yoon, Michael K.
    Wolkow, Natalie
    Lee, Nahyoung Grace
    Freitag, Suzanne K.
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2024, 40 (05): : 583 - 583
  • [37] Teprotumumab (Tepezza)-related hyperglycemia in thyroid eye disease
    Lang, Tracy
    Rael, Aaron
    Park, Kristen
    Sudharshan, Rasika
    Chang, Jessica R.
    Zhang-Nunes, Sandy
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [38] Effects of Teprotumumab on Eyelid Retraction in Thyroid Eye Disease
    Al-Sharif, Eman M.
    Zhou, Jason
    Shoji, Marissa K.
    Acuff, Kaela
    Liu, Catherine Y.
    Korn, Bobby S.
    Kikkawa, Don O.
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2025, 41 (01): : 22 - 27
  • [39] Teprotumumab, a Novel Biologic for Active Thyroid Eye Disease
    Kahaly, George.
    Sile, Saba
    Thompson, Elizabeth H.
    Vescio, Thomas
    Perdok, Renee
    Sherman, Jeffrey W.
    Smith, Terry J.
    Douglas, Raymond S.
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [40] Teprotumumab and the Evolving Therapeutic Landscape in Thyroid Eye Disease
    Kossler, Andrea Lora
    Douglas, Raymond
    Dosiou, Chrysoula
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 : S36 - S46
12345